Benjamin Wu
Family Practice · Brooklyn, NYNPI 1275639502
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 403 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Among family practice clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 403 payments — averaging $39.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Amgen$2K
- Boehringer Ingelheim$2K
- GSK$2K
- Gilead$1K
- Bayer$754
- plus $5K from 27 others
What the payments were for
- Food & beverage$15,839100%
- Education$630%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 73 | $3,149 |
| Amgen(2 entities) | 52 | $2,161 |
| Boehringer Ingelheim | 30 | $1,839 |
| GSK | 36 | $1,597 |
| Gilead | 49 | $1,276 |
| Bayer | 21 | $754 |
| AbbVie(2 entities) | 14 | $643 |
| Novo Nordisk | 12 | $629 |
| Kowa Pharmaceuticals America, Inc. | 15 | $388 |
| Boston Scientific | 3 | $385 |
| Esperion Therapeutics, Inc. | 12 | $362 |
| Insmed, Inc. | 8 | $357 |
| Lilly USA, LLC | 11 | $300 |
| Johnson & Johnson | 8 | $236 |
| Angiodynamics, Inc. | 2 | $210 |
| Exact Sciences | 9 | $190 |
| Alcon | 1 | $147 |
| Abbott | 1 | $136 |
| Medtronic | 1 | $135 |
| Nestle Healthcare Nutrition Inc. | 6 | $133 |
| Pfizer | 7 | $125 |
| IBSA Pharma Inc. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $119 |
| Cumberland Pharmaceuticals, Inc. | 7 | $91 |
| Merck | 6 | $90 |
| Ardelyx, Inc. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $43 |
| Cordis US CORP. | 2 | $39 |
| Agios Pharmaceuticals, Inc. | 1 | $22 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,902 in reported general payments places this provider in the 95th percentile of 792 family practice providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VascepaIcosapent Ethyl | 1,298 | $615,509 |
| Diclofenac Epolamine | 631 | $399,889 |
| JardianceEmpagliflozin | 448 | $382,967 |
| FarxigaDapagliflozin Propanediol | 353 | $299,424 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 341 | $235,399 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 309 | $224,801 |
| LinzessLinaclotide | 282 | $201,736 |
| Diclofenac Sodium | 451 | $199,147 |
| JanuviaSitagliptin Phosphate | 231 | $190,325 |
| ProliaDenosumab | 110 | $183,867 |
| EliquisApixaban | 228 | $164,333 |
| JanumetSitagliptin Phos/Metformin Hcl | 189 | $147,610 |
| Xigduo XrDapaglifloz Propaned/Metformin | 143 | $144,637 |
| VemlidyTenofovir Alafenamide | 95 | $136,689 |
| Evenity (2 Syringes)Romosozumab-Aqqg | 46 | $111,124 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta, Glyxambi, Jentadueto | $1,839 | $673,184829 claims |
| MerckJanumet Xr, Januvia, Janumet | $90 | $573,334761 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $3,149 | $418,984554 claims |
| AbbVieLinzess, Restasis, Namzaric, Creon | $643 | $347,367479 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $1,597 | $328,346521 claims |
| AmgenProlia, Evenity (2 Syringes) | $2,161 | $294,991156 claims |
| PfizerEliquis | $125 | $164,333228 claims |
| GileadVemlidy | $1,276 | $136,68995 claims |
| Novo NordiskRybelsus, Ozempic | $629 | $88,71774 claims |
| Astellas Pharma US IncMyrbetriq | $43 | $53,16794 claims |
| Johnson & JohnsonXarelto | $236 | $48,21555 claims |
| Lilly USA, LLCTrulicity | $300 | $37,78128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 792 family practice providers in New York.
Other family practice in Brooklyn
- Cuong leBrooklyn$27
- Filomena LombardiBrooklyn$0
- Arundhati MarballiBrooklyn$0
- Carmen FamiliaBronx$11K
- Rosanne CebelenskiDeer Park$10K
- Sumathy ReddyIsland Park$4K
- Yagnasri EagalaNew Hartford$2K
- Kristen MerolaSyracuse$1K
- Kristen MailandEast Setauket$934
- Rashid GirshabUtica$923
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.